From drug pricing to reforming the drug regulatory process, Trump’s re-election has plenty of implications for the pharma ...

Greetings and welcome to Rigel Pharmaceutical's Financial Conference Call for the Third Quarter 2024. At this time, all participants are in a listen-only mode. A brief question and answer session will ...

As Trump gears up to reenter the White House and bring RFK Jr. with him, Kennedy has signaled what exactly his role would look like.

ANI Pharmaceuticals (ANIP) came out with quarterly earnings of $1.34 per share, beating the Zacks Consensus Estimate of $1.09 per share. This compares to earnings of $1.27 per share a year ago. These ...

The additional recruitments will help the Drugs Controller General of India enforce good manufacturing practices for ...

President Trump spent much of his first term skirmishing with the press. In his second term, it could become all-out ...

For example, the BRS government acquired land for the setting up of Pharma City. Now, we have taken a decision ... Due to ...

AstraZeneca’s presence in South Africa has become a driving force in global health research, contributing significantly to respiratory, cardiovascular, and oncology therapeutic areas. The ...

Area researchers are helping investigate the promise and the perils of psychedelic drugs as public interest grows.

Market analyst Sandip Sabharwal sees potential in IDFC First Bank after a 35% drop, citing strong asset quality. He's also keeping an eye on SBI's results, particularly its asset quality and CASA ...

Andrew Fein, an analyst from H.C. Wainwright, reiterated the Buy rating on Catalyst Pharma (CPRX – Research Report). The associated price ...